Evidence map›Paper›PMID 21832245›Full record

ArticleAmerican journal of physiology. Cell physiology2011

Aldosterone stimulates vacuolar H(+)-ATPase activity in renal acid-secretory intercalated cells mainly via a protein kinase C-dependent pathway.

Christian Winter, Nicole B Kampik, Luca Vedovelli, Florina Rothenberger, Teodor G Paunescu, Paul A Stehberger, Dennis Brown, Hubert John, Carsten A Wagner

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Vasopressin Increases Urinary AcidificationJournal of the American Society of Nephrology : JASN · 2019
    Article
  9. Review
  10. Article
  11. Characterization and Correction of Olfactory Deficits in Kidney Disease.Journal of the American Society of Nephrology : JASN · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Christian WinterInstitute of Physiology, Center for Integrative Human Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich Switzerland.
Nicole B Kampik
Luca Vedovelli
Florina Rothenberger
Teodor G Paunescu
Paul A Stehberger
Dennis Brown
Hubert John
Carsten A Wagner
Center for Systems Biology · USUniversity of Zurich · CHSwiss Integrative Center for Human Health · CHKantonsspital Winterthur · CH

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ANDREW D LUSTER · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Regulation of proton pump trafficking in kidneyR37DK042956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2008 to 2017
$4.0M
CELLULAR REGULATION OF KIDNEY EPITHELIAL CELL POLARITYR01DK042956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 1991 to 2006
$2.2M
Regulation of V-ATPase-mediated Renal Proton SecretionK01DK073266 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PAUNESCU, TEODOR G. · 2006 to 2010
$723k
Regulation of proton pump trafficking in kidneyR56DK042956 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2018 to 2018
$100k
NIDDK NIH HHS DK-42956NIDDK NIH HHS DK-43351NIDDK NIH HHS DK-57521NIDDK NIH HHS DK-73266NIDDK NIH HHS K01 DK073266NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK042956NIDDK NIH HHS R37 DK042956NIDDK NIH HHS R56 DK042956
6 · The paper itself

Abstract

Urinary acidification in the collecting duct is mediated by the activity of H(+)-ATPases and is stimulated by various factors including angiotensin II and aldosterone. Classically, aldosterone effects are mediated via the mineralocorticoid receptor. Recently, we demonstrated a nongenomic stimulatory effect of aldosterone on H(+)-ATPase activity in acid-secretory intercalated cells of isolated mouse outer medullary collecting ducts (OMCD). Here we investigated the intracellular signaling cascade mediating this stimulatory effect. Aldosterone stimulated H(+)-ATPase activity in isolated mouse and human OMCDs. This effect was blocked by suramin, a general G protein inhibitor, and GP-2A, a specific G(αq) inhibitor, whereas pertussis toxin was without effect. Inhibition of phospholipase C with U-73122, chelation of intracellular Ca(2+) with BAPTA, and blockade of protein kinase C prevented the stimulation of H(+)-ATPases. Stimulation of PKC by DOG mimicked the effect of aldosterone on H(+)-ATPase activity. Similarly, aldosterone and DOG induced a rapid translocation of H(+)-ATPases to the luminal side of OMCD cells in vivo. In addition, PD098059, an inhibitor of ERK1/2 activation, blocked the aldosterone and DOG effects. Inhibition of PKA with H89 or KT2750 prevented and incubation with 8-bromoadenosine-cAMP mildly increased H(+)-ATPase activity. Thus, the nongenomic modulation of H(+)-ATPase activity in OMCD-intercalated cells by aldosterone involves several intracellular pathways and may be mediated by a G(αq) protein-coupled receptor and PKC. PKA and cAMP appear to have a modulatory effect. The rapid nongenomic action of aldosterone may participate in the regulation of H(+)-ATPase activity and contribute to final urinary acidification.

Indexed as

8-Bromo Cyclic Adenosine MonophosphateAldosteroneAnimalsChelating AgentsDiglyceridesEgtazic AcidEnzyme InhibitorsEstrenesFlavonoidsGTP-Binding ProteinsHumansIsoquinolinesKidney Tubules, CollectingMaleMiceMice, Inbred C57BL1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid1,2-dioctanoylglycerol1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one8-Bromo Cyclic Adenosine MonophosphateAldosteroneChelating AgentsDiglyceridesEgtazic AcidEnzyme InhibitorsEstrenesFlavonoidsGTP-Binding ProteinsIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePertussis ToxinProtein Kinase CPyrrolidinonesSulfonamidesSuraminType C PhospholipasesVacuolar Proton-Translocating ATPases

Identifiers

PMID21832245
PMCPMC3213922
OpenAlexW2062554486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.